youtube_live
Pendapatan Q3 2026 • dikeluarkan • EPS melebihi +8.62% • Hasil melebihi +2.31%
Lihat hasilchevron_right
EW:NYSE
Edwards Lifesciences Corp
USD 100.82
arrow_upward
+1.46%(+1.45) 1H
USD 100.00
arrow_downward
-0.81% (-0.82)bedtimeSelepas waktu pejabat
Ditutup: 5 Nov, 4:00:05 PTG GMT-5 · USD
search
Semua simbol
| Simbol | Harga | Perubahan | % Perubahan |
|---|
insights_autoMenjana cerapan popular untuk EW...
Buka
USD 100.67
Tinggi
USD 104.16
Rendah
USD 98.77
Permodalan Pasaran
58.11B
Purata volum
4.14J
Volum
9.23J
Nisbah H/P
58.33
tgi 52 mgu
USD 104.16
rdh 52 mgu
USD 74.66
EPS
USD 1.73
Beta
0.85
Syer tertunggak
576.40J
Bilangan pekerja
16K
Buka
USD 100.67
Tinggi
USD 104.16
Rendah
USD 98.77
Permodalan Pasaran
58.11B
Purata volum
4.14J
Volum
9.23J
Nisbah H/P
58.33
tgi 52 mgu
USD 104.16
rdh 52 mgu
USD 74.66
EPS
USD 1.73
Beta
0.85
Syer tertunggak
576.40J
Bilangan pekerja
16K
Cerita berita
Daripada sumber web dan rakan kongsi berita
Yahoo Finance
·
7 jam lalu
CAH Shares Post New Record, EW Stock Hits Over Three-Year High – What’s Driving Today’s Rally?
GuruFocus
·
8 jam lalu
Edwards Lifesciences Corp (EW) (Q3 2026) Earnings Call Highlight
Investing.com
·
9 jam lalu
Edwards Lifesciences stock rating reiterated at Buy by TD Cowen
Profil
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
Perihal Edwards Lifesciences Corp
CEO-
Pekerja16K
Diasaskan1958
Ibu pejabatIrvine, California, Amerika Syarikat
SektorHealth Care
Industri-
Laman webedwards.com